126 related articles for article (PubMed ID: 22053777)
1. Dicer-labile PEG conjugates for siRNA delivery.
Kow SC; McCarroll J; Valade D; Boyer C; Dwarte T; Davis TP; Kavallaris M; Bulmus V
Biomacromolecules; 2011 Dec; 12(12):4301-10. PubMed ID: 22053777
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight.
Jung S; Lee SH; Mok H; Chung HJ; Park TG
J Control Release; 2010 Jun; 144(3):306-13. PubMed ID: 20206653
[TBL] [Abstract][Full Text] [Related]
3. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of siRNA with comb-type PEG enhances serum stability and gene silencing efficiency.
Gunasekaran K; Nguyen TH; Maynard HD; Davis TP; Bulmus V
Macromol Rapid Commun; 2011 Apr; 32(8):654-9. PubMed ID: 21480423
[TBL] [Abstract][Full Text] [Related]
5. Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing.
Abe M; Suzuki H; Nishitsuji H; Shida H; Takaku H
FEBS Lett; 2010 Oct; 584(20):4313-8. PubMed ID: 20869963
[TBL] [Abstract][Full Text] [Related]
6. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration.
Ambardekar VV; Wakaskar RR; Ye Z; Curran SM; McGuire TR; Coulter DW; Singh RK; Vetro JA
Int J Pharm; 2018 May; 543(1-2):130-138. PubMed ID: 29601972
[TBL] [Abstract][Full Text] [Related]
7. Use of microarrays in transfection of mammalian cells with dicer-digested small interfering RNAs.
Fujimoto H; Kato K; Iwata H
Anal Biochem; 2008 Mar; 374(2):417-22. PubMed ID: 18201542
[TBL] [Abstract][Full Text] [Related]
8. HCV core protein interacts with Dicer to antagonize RNA silencing.
Chen W; Zhang Z; Chen J; Zhang J; Zhang J; Wu Y; Huang Y; Cai X; Huang A
Virus Res; 2008 May; 133(2):250-8. PubMed ID: 18325616
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
Kim SH; Mok H; Jeong JH; Kim SW; Park TG
Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
[TBL] [Abstract][Full Text] [Related]
10. In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.
Kubo T; Yanagihara K; Seyama T
Chem Biol Drug Des; 2016 Jun; 87(6):811-23. PubMed ID: 26800111
[TBL] [Abstract][Full Text] [Related]
11. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
12. [The effect of silencing Dicer by small interference RNA on the biological characteristics of human glioma cells].
Zhang AL; Kang CS; Han L; Wang GX; Jia ZF; Pu PY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):521-4. PubMed ID: 19806572
[TBL] [Abstract][Full Text] [Related]
13. Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer.
Ye Z; Abdelmoaty MM; Ambardekar VV; Curran SM; Dyavar SR; Arnold LL; Cohen SM; Kumar D; Alnouti Y; Coulter DW; Singh RK; Vetro JA
Nanomedicine; 2021 Apr; 33():102363. PubMed ID: 33545405
[TBL] [Abstract][Full Text] [Related]
14. RNA interference in vitro and in vivo using DsiRNA targeting the nucleocapsid N mRNA of human metapneumovirus.
Darniot M; Schildgen V; Schildgen O; Sproat B; Kleines M; Ditt V; Pitoiset C; Pothier P; Manoha C
Antiviral Res; 2012 Mar; 93(3):364-73. PubMed ID: 22285728
[TBL] [Abstract][Full Text] [Related]
15. Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing.
Chung HJ; Hong CA; Lee SH; Jo SD; Park TG
Bioconjug Chem; 2011 Feb; 22(2):299-306. PubMed ID: 21222435
[TBL] [Abstract][Full Text] [Related]
16. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
[TBL] [Abstract][Full Text] [Related]
17. Branched RNA nanostructures for RNA interference.
Nakashima Y; Abe H; Abe N; Aikawa K; Ito Y
Chem Commun (Camb); 2011 Aug; 47(29):8367-9. PubMed ID: 21691656
[TBL] [Abstract][Full Text] [Related]
18. The contributions of dsRNA structure to Dicer specificity and efficiency.
Vermeulen A; Behlen L; Reynolds A; Wolfson A; Marshall WS; Karpilow J; Khvorova A
RNA; 2005 May; 11(5):674-82. PubMed ID: 15811921
[TBL] [Abstract][Full Text] [Related]
19. Polyethylenimine grafted with diblock copolymers of polyethylene glycol and polycaprolactone as siRNA delivery vector.
Huang W; Lv M; Gao Z
J Control Release; 2011 Nov; 152 Suppl 1():e143-5. PubMed ID: 22195810
[No Abstract] [Full Text] [Related]
20. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
